S.I. No. 438/2026 - Misuse of Drugs (Amendment) (No. 2) Regulations 2026

Type Statutory Instrument
Publication 2026-08-25
State In force
Text As published
articles 5

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

Reform history JSON API

Notice of the making of this Statutory Instrument was published in

“Iris Oifigiúil” of 25th August, 2026.

I, JENNIFER CARROLL MACNEILL, Minister for Health, in exercise of the powers conferred on me by sections 4 , 5 (amended by section 3 of the Misuse of Drugs (Amendment) Act 2016 (No. 9 of 2016)), 18 and 38 of the Misuse of Drugs Act 1977 (No. 12 of 1977) and section 5 of the Misuse of Drugs Act 1984 (No. 18 of 1984), hereby make the following regulations:

1.

1.

(1) These Regulations may be cited as the Misuse of Drugs (Amendment) (No. 2) Regulations 2026.

2.

2.

In these Regulations, “Principal Regulations” means the Misuse of Drugs Regulations 2017 ( S.I. No. 173 of 2017 ).

3.

3.

Schedule 1 to the Principal Regulations is amended, in paragraph 1(a), by—

“2-[(4-Ethoxyphenyl)methyl]-N,N-diethyl-1H-benzimidazole-1-ethanamine (otherwise known as Etazene)

2-[(4-Ethoxyphenyl)methyl]-5-nitro-1-(2-piperidin-1-ylethyl)-1H-benzoimidazole (otherwise known as Etonitazepipne)

2-[(4-Ethoxyphenyl)methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)-1H-benzoimidazole (otherwise known as Etonitazepyne)

N-ethyl-2-[2-[(4-isopropoxyphenyl)methyl]-5-nitro-benzimidazol-1-yl]ethanamine (otherwise known as N-desethyl isotonitazene)”,

“Hexahydrocannabinol

Hexahydro derivatives of 3-alkyl homologues of cannabinol”,

“1-{2-methyl-4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1-yl}butan-1-one (otherwise known as 2-methyl-AP-237)

5-nitro-2-[(4-propoxyphenyl)methyl]-1-(2-pyrrolidin-1-ylethyl)benzimidazole (otherwise known as Protonitazepyne)”.

4.

4.

Schedule 4 to the Principal Regulations is amended, in Part 1, by—

5.

5.

The Misuse of Drugs (Amendment) Regulations 2025 (S.I. No. 405/2025) are revoked.

GIVEN under my Official Seal,

29 July, 2026.

JENNIFER CARROLL MACNEILL,

Minister for Health.

EXPLANATORY NOTE

(This note is not part of the Instrument and does not purport to be a legal interpretation.)

The purpose of these Regulations is to amend the Misuse of Drugs Regulations 2017 by adding certain additional substances to Schedules 1 and 4 of those Regulations.

These Regulations may be cited as the Misuse of Drugs (Amendment) (No. 2) Regulations 2026.

This document does not substitute the official text published in the Irish Statute Book. We accept no responsibility for any inaccuracies arising from the transcription of the original into this format.

This text is published under Irish Statute Book's own terms of reuse, not a Legalize or public-domain licence. Irish Statute Book
CC-BY 4.0 (Oireachtas Open Data PSI Licence)
Contains Irish Public Sector Information licensed under the Oireachtas (Houses of the Oireachtas) Open Data PSI Licence / Creative Commons Attribution 4.0 International, sourced from https://www.irishstatutebook.ie.